Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;42(12):1521-1547.
doi: 10.1002/humu.24275. Epub 2021 Sep 20.

PRPH2 mutation update: In silico assessment of 245 reported and 7 novel variants in patients with retinal disease

Manon H C A Peeters  1   2 , Mubeen Khan  1   2 , Anoek A M B Rooijakkers  1 , Timo Mulders  2   3 , Lonneke Haer-Wigman  1 , Camiel J F Boon  4   5 , Caroline C W Klaver  2   3   6   7 , L Ingeborgh van den Born  8   9 , Carel B Hoyng  2   3 , Frans P M Cremers  1   2 , Anneke I den Hollander  1   2   3 , Claire-Marie Dhaenens  1   10 , Rob W J Collin  1   2
Affiliations

PRPH2 mutation update: In silico assessment of 245 reported and 7 novel variants in patients with retinal disease

Manon H C A Peeters et al. Hum Mutat. 2021 Dec.

Abstract

Mutations in PRPH2, encoding peripherin-2, are associated with the development of a wide variety of inherited retinal diseases (IRDs). To determine the causality of the many PRPH2 variants that have been discovered over the last decades, we surveyed all published PRPH2 variants up to July 2020, describing 720 index patients that in total carried 245 unique variants. In addition, we identified seven novel PRPH2 variants in eight additional index patients. The pathogenicity of all variants was determined using the ACMG guidelines. With this, 107 variants were classified as pathogenic, 92 as likely pathogenic, one as benign, and two as likely benign. The remaining 50 variants were classified as variants of uncertain significance. Interestingly, of the total 252 PRPH2 variants, more than half (n = 137) were missense variants. All variants were uploaded into the Leiden Open source Variation and ClinVar databases. Our study underscores the need for experimental assays for variants of unknown significance to improve pathogenicity classification, which would allow us to better understand genotype-phenotype correlations, and in the long-term, hopefully also support the development of therapeutic strategies for patients with PRPH2-associated IRD.

Keywords: LOVD; PRPH2; in silico assessment; inherited retinal disease; molecular genetics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Figures

Figure 1
Figure 1
(a) Pie‐chart showing the distribution of (likely) pathogenic PRPH2 variants in IRD patients. (b) Pie‐chart showing the ACMG pathogenicity assessment of missense variants. About two‐thirds of the missense variants were classified as pathogenic or likely pathogenic. (c) Location likely pathogenic missense variants relative to the protein structure. The vast majority of the likely pathogenic missense variants are located in the D2 loop. AMD, age‐related macular degeneration; AVMD, adult vitelliform macular dystrophy; CD, cone dystrophy; CRD, cone‐rod dystrophy; EOHM, early‐onset high myopia; IRD, inherited retinal disease; PD, pattern dystrophy; RP, retinitis pigmentosa
See this image and copyright information in PMC

References

    1. Abouelhoda, M. , Faquih, T. , El‐Kalioby, M. , & Alkuraya, F. S. (2016). Revisiting the morbid genome of Mendelian disorders. Genome Biology, 17(1), 235. 10.1186/s13059-016-1102-1 - DOI - PMC - PubMed
    1. Abu‐Safieh, L. , Alrashed, M. , Anazi, S. , Alkuraya, H. , Khan, A. O. , Al‐Owain, M. , Al‐Zahrani, J. , Al‐Abdi, L. , Hashem, M. , Al‐Tarimi, S. , Sebai, M. A. , Shamia, A. , Ray‐Zack, M. D. , Nassan, M. , Al‐Hassnan, Z. N. , Rahbeeni, Z. , Waheeb, S. , Alkharashi, A. , Abboud, E. , … Alkuraya, F. S. (2013). Autozygome‐guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes. Genome Research, 23(2), 236–247. 10.1101/gr.144105.112 - DOI - PMC - PubMed
    1. Adzhubei, I. , Jordan, D. M. , & Sunyaev, S. R. (2013). Predicting functional effect of human missense mutations using PolyPhen‐2. Current Protocols in Human Genetics, 20. 10.1002/0471142905.hg0720s76 - DOI - PMC - PubMed
    1. Ahmad, O. R. , Ayyagari, R. , & Zacks, D. N. (2010). A novel missense mutation in the rds/peripherin gene associated with retinal pattern dystrophy. Retinal Cases & Brief Reports, 4(1), 84–85. 10.1097/ICB.0b013e318198d8f7 - DOI - PubMed
    1. Alapati, A. , Goetz, K. , Suk, J. , Navani, M. , Al‐Tarouti, A. , Jayasundera, T. , Tumminia, S. J. , Lee, P. , & Ayyagari, R. (2014). Molecular diagnostic testing by eyeGENE: Analysis of patients with hereditary retinal dystrophy phenotypes involving central vision loss. Investigative Ophthalmology and Visual Science, 55(9), 5510–5521. 10.1167/iovs.14-14359 - DOI - PMC - PubMed

Publication types